Sutro Biopharma (STRO)
(Delayed Data from NSDQ)
$3.42 USD
0.00 (0.00%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.42 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.91 |
EPS Last Quarter | 0.42 |
Last EPS Surprise | 151.22% |
ABR | 1.20 |
Earnings ESP
|
0.14% |
---|---|
Current Year | -3.15 |
Next Year | -3.05 |
EPS (TTM) | -1.79 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.57M | 27.38M | 80.41M | 66.93M |
# of Estimates | 6 | 6 | 7 | 6 |
High Estimate | 24.65M | 69.27M | 214.86M | 204.86M |
Low Estimate | 5.04M | 5.18M | 24.00M | 15.07M |
Year ago Sales | 12.67M | 10.41M | 153.73M | 80.41M |
Year over Year Growth Est. | -8.72% | 162.97% | -47.69% | -16.77% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.91 | -0.64 | -3.15 | -3.05 |
# of Estimates | 7 | 6 | 8 | 8 |
Most Recent Consensus | -0.73 | -0.10 | -2.37 | -2.75 |
High Estimate | -0.72 | -0.03 | -0.76 | -0.74 |
Low Estimate | -1.09 | -1.04 | -4.27 | -4.36 |
Year ago EPS | -0.76 | -0.64 | -1.91 | -3.15 |
Year over Year Growth Est. | -19.74% | 0.00% | -64.92% | 2.91% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 2 | 4 | 2 |
Up Last 60 Days | 1 | 2 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 2 |
Down Last 60 Days | 2 | 2 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.91 | -0.64 | -3.15 | -3.05 |
7 Days Ago | -0.91 | -0.64 | -3.15 | -3.05 |
30 Days Ago | -0.93 | -0.94 | -3.51 | -3.21 |
60 Days Ago | -0.84 | -0.40 | -3.23 | -2.73 |
90 Days Ago | -0.84 | -0.40 | -3.23 | -2.73 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.91 | -0.49 | -2.90 | -2.85 |
Zacks Consensus Estimate | -0.91 | -0.64 | -3.15 | -3.05 |
Earnings ESP | 0.14% | 23.06% | 7.84% | 6.51% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.42 | -0.81 | -0.64 | -0.76 | NA |
Estimate | -0.82 | -0.76 | -0.73 | -0.83 | NA |
Difference | 1.24 | -0.05 | 0.09 | 0.07 | 0.34 |
Surprise | 151.22% | -6.58% | 12.33% | 8.43% | 41.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more